Biggest News Aggregation in the World
📰 Statement Regarding News

Page 69 - Statement Regarding News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Statement Regarding. Real-time updates on events, politics, business and more.

Defence Therapeutics Inc.: Defence Therapeutics Cancer Vaccine AccuVac-D001 Manufacturing Targets Melanoma and Breast Cancer

Vancouver, British Columbia--(Newsfile Corp. - November 23, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a biotechnology company working on cancer
United Kingdom British Columbia Nicoletta Eliopoulos Sebastien Plouffe Defence Therapeutics Inc British Columbia Newsfile Corp

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER

DGAP-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous23.11.2021 / 08:30 The issuer is solely responsible for the content of this announcement.CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASEDEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER Vancouver, BC, Canada...
British Columbia Nicoletta Eliopoulos Sebastien Plouffe Defence Therapeutics Inc Lady Davis Institute Laboratory Annex

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Defence Therapeutics Inc.: Defence Therapeutics Reports Successful Completion of Its COVID-19 Vaccine AccuVAC-PT001 Toxicology Studies in Rabbits

Vancouver, British Columbia--(Newsfile Corp. - November 3, 2021) - Defence Therapeutics Inc. (CSE: DTC) (OTC Pink: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a biotechnology company working on the
United Kingdom British Columbia Sebastien Plouffe Moutih Rafei Defence Vp Research Defence Therapeutics Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science